AtreMorine was found to be neuroprotective in a triple-transgenic mouse model of AD by upregulating DNMT3a mRNA expression and increasing global DNA methylation while lowering HDAC3 expression. This evidence concerns the gene HDAC3 and Alzheimer disease.